Pulse Pharma

Pulse Pharma operates through Pulse Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.

1 investors in total: 1 institutional.

Pulse Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Spark Capital.

All

Venture Fund

Investor	Description	Founded Year	Domain	Location
Spark Capital	Spark Capital is engaged in venture capital investments.	–	sparkcapital.com	San Francisco, United States

Premium access

Investor details for Pulse Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

• Complete investor list
• Round participation
• Investor portfolios
• Co-investor network

Access investors

Verified entity values are shown only after access is granted.

Pulse Pharmaceuticals Private Limited is the primary company behind Pulse Pharma. The board of Pulse Pharmaceuticals Private Limited currently have 6 directors; the longest-serving is Venkat Ram Babu Katragadda, appointed in 1997. 9 earlier directors have ceased.

19 people are tracked at Pulse Pharma (13 in leadership, 6 in team); the tracked headcount is 954.

Figures of Pulse Pharmaceuticals Private Limited, the primary company behind Pulse Pharma, for FY 2024. Revenue was ₹145 Cr (-1% year on year). Net loss was -₹14.74 Cr (-10% margin). EBITDA was ₹2.25 Cr (2% margin). Revenue has grown at a compounded annual rate of +8% over three years and -30% over five years.

• ₹145 CrRevenue · FY 2024 · -1% YoY
• -₹14.74 CrNet loss · -10% margin
• ₹2.25 CrEBITDA · 2% margin
• ₹7.94 CrPaid-up capital
• 954Employees (provident fund records)
• +8%Revenue CAGR, 3 years
• -30%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Pulse Pharmaceuticals Private Limited are on its company page.

2 dated milestones of Pulse Pharma across 26 years, from founding to its latest funding, stage changes and deals.

1. 1997 Founded Pulse Pharma is founded.
2. May 2023 Funding First funding round of $183K.

The website of Pulse Pharma (pulsepharma.net) receives about 2.5K visits a month.

• Monthly visits
  2.5K

  ▲ 12% vs previous month

10 companies that operate in the same segment as Pulse Pharma (Traditional Health & Nutrition), ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Amneal	Manufacturer of generics formulations	2002	Bridgewater, New Jersey, United States	–	USD 3.02 B	8,300
Coherus Biosciences	Biosimilar therapeutics are developed for oncology and autoimmune diseases.	2010	Redwood City, California, United States	USD 143.62 M	USD 42.17 M	228
Inventia Healthcare	Oral solid drug delivery systems are manufactured and developed.	1985	Mumbai, Maharashtra, India	USD 42.49 M	USD 89.42 M	962
Bausch & Lomb	Ophthalmic pharmaceuticals and instruments are developed for eye care.	1853	Bridgewater, New Jersey, United States	–	USD 5.1 B	13,500
Teva Pharmaceuticals	Generic pharmaceuticals are manufactured by Teva Pharmaceuticals.	1901	Petah Tikva, Central District, Israel	USD 500 M	USD 18.74 B	51,792
Strides Pharma Science	Generic, semi-solid, and liquid dosage forms are manufactured.	1990	Bengaluru, Karnataka, India	–	USD 508.93 M	5,180
Alvogen	Pharmaceutical products are developed and marketed globally.	2009	Montville, New Jersey, United States	USD 155.92 M	–	–
Sun Pharma	Specialty generic pharmaceuticals and APIs are manufactured and marketed.	1983	Mumbai, Maharashtra, India	–	USD 6.21 B	25,870
Mankind Pharma	Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations	1991	Delhi, Delhi, India	USD 367.2 M	USD 1.52 B	21,320
Wockhardt	Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt.	1967	Mumbai, Maharashtra, India	–	USD 353.53 M	3,410